Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report.

Authors :: Driessen C
Noppen C
Boonen G
Drewe J
Source :: Clinical case reports [Clin Case Rep] 2021 Oct 06; Vol. 9 (10), pp. e04903. Date of Electronic Publication: 2021 Oct 06 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.<br />Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this article.<br /> (© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)

Full Text Access

Tools